Too many Volvo’s going on vacation while the reps haven’t made a real sales call in 6 months. The stock will slightly rebound when the dead wood is hacked away
Nothing really spectacular with the stock this year. At least it barely shit out a 3% dividend. Signed, Not impressed with the CEO
If shareholders knew BMS really doesn’t know how to launch a new division it would be worse. Over projecting on me too products will be obvious to everyone soon. Over projecting on future products will proven as well. What a disappointment it has been launching one, pandemic or not.
Poor performing stock in 2020 despite the sector rising. Dividend coming in Feb 2021 is tepid at best. It Might Not Be A Great Idea To Buy Bristol-Myers Squibb Company (NYSE:BMY) For Its Next Dividend
Not shaping up well as the pharma broader sector has been moving of late during earnings season. The addition of CAR-T therapy was interpreted as Ho-Hum on Wall Street. Guys, Gals - this is a dividend stock at best. Just saying...